MHRA Guidance on Decentralized Clinical Trials in the UK
MHRA Guidance on Decentralized Clinical Trials in the UK MHRA’s Guidance on Decentralized Clinical Trials in the UK Decentralized clinical trials (DCTs), often referred to as virtual or remote trials, are transforming how clinical research is conducted globally. In the United Kingdom (UK), the Medicines and Healthcare products Regulatory Agency (MHRA) has taken proactive steps…
Read More “MHRA Guidance on Decentralized Clinical Trials in the UK” »